首页 > 最新文献

Annals of Thoracic Medicine最新文献

英文 中文
Joint consensus statement of the Saudi Public Health Authority on the recommended amount of physical activity, sedentary behavior, and sleep duration for healthy Saudis: Background, methodology, and discussion. 沙特公共卫生局关于健康沙特人建议的体育活动量、久坐行为和睡眠时间的联合共识声明:背景、方法和讨论。
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2021-07-01 Epub Date: 2021-07-20 DOI: 10.4103/atm.atm_32_21
Ahmed S BaHammam, Abdullah F Alghannam, Khalid Saad Aljaloud, Ghadeer S Aljuraiban, Mezna A AlMarzooqi, Ali M Dobia, Shaima A Alothman, Osama Aljuhani, Rasha A Alfawaz

The Saudi Public Health Authority recently prepared a Consensus Statement regarding how much time a person should spend engaged in physical activity, sedentary behavior, and sleep to promote optimal health across all age groups. This paper describes the background literature, methodology, and modified RAND Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-ADOLOPMENT approach that guided the development process. A Leadership Group and Consensus Panels were formed, and credible existing guidelines were identified. The Panel identified clear criteria to choose the best practice guidelines for the set objectives after evaluation, based on GRADE table evidence, findings table summaries, and draft recommendations. Updating of the selected practice guidelines was performed, and the Consensus Panels separately reviewed the evidence for each behavior and decided to adopt or adapt the selected practice guideline recommendations or create de novo recommendations. Data related to cultural factors that may affect the studied behaviors, such as prayer times, midday napping or "Qailulah," and the holy month of Ramadan, were also reviewed. Two rounds of voting were conducted to reach a consensus for each behavior.

沙特公共卫生局最近编制了一份共识声明,内容涉及一个人应该花多少时间从事体育活动、久坐行为和睡眠,以促进所有年龄组的最佳健康。本文介绍了指导开发过程的背景文献、方法和修改后的RAND适当性方法和建议评估、开发和评估分级(GRADE)-ADOLOPMENT方法。成立了一个领导小组和协商小组,并确定了可信的现有准则。专家小组根据GRADE表证据、调查结果表摘要和建议草案,确定了在评估后为既定目标选择最佳做法指南的明确标准。对选定的实践指南进行了更新,共识小组分别审查了每种行为的证据,并决定采用或调整选定的实践准则建议或重新制定建议。还回顾了可能影响研究行为的文化因素相关数据,如祈祷时间、午休或“Qailulah”以及斋月。为了对每种行为达成共识,进行了两轮投票。
{"title":"Joint consensus statement of the Saudi Public Health Authority on the recommended amount of physical activity, sedentary behavior, and sleep duration for healthy Saudis: Background, methodology, and discussion.","authors":"Ahmed S BaHammam,&nbsp;Abdullah F Alghannam,&nbsp;Khalid Saad Aljaloud,&nbsp;Ghadeer S Aljuraiban,&nbsp;Mezna A AlMarzooqi,&nbsp;Ali M Dobia,&nbsp;Shaima A Alothman,&nbsp;Osama Aljuhani,&nbsp;Rasha A Alfawaz","doi":"10.4103/atm.atm_32_21","DOIUrl":"10.4103/atm.atm_32_21","url":null,"abstract":"<p><p>The Saudi Public Health Authority recently prepared a Consensus Statement regarding how much time a person should spend engaged in physical activity, sedentary behavior, and sleep to promote optimal health across all age groups. This paper describes the background literature, methodology, and modified RAND Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-ADOLOPMENT approach that guided the development process. A Leadership Group and Consensus Panels were formed, and credible existing guidelines were identified. The Panel identified clear criteria to choose the best practice guidelines for the set objectives after evaluation, based on GRADE table evidence, findings table summaries, and draft recommendations. Updating of the selected practice guidelines was performed, and the Consensus Panels separately reviewed the evidence for each behavior and decided to adopt or adapt the selected practice guideline recommendations or create <i>de novo</i> recommendations. Data related to cultural factors that may affect the studied behaviors, such as prayer times, midday napping or \"Qailulah,\" and the holy month of Ramadan, were also reviewed. Two rounds of voting were conducted to reach a consensus for each behavior.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1d/2a/ATM-16-225.PMC8388569.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39385979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
The efficacy of airway pressure release ventilation in acute respiratory distress syndrome adult patients: A meta-analysis of clinical trials. 急性呼吸窘迫综合征成人患者气道压力释放通气的疗效:临床试验荟萃分析。
IF 2.1 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-07-01 Epub Date: 2021-07-20 DOI: 10.4103/atm.ATM_475_20
Fatmah Othman, Noura Alsagami, Reem Alharbi, Yara Almuammer, Shatha Alshahrani, Taha Ismaeil

Background: To recruit poorly ventilated lung areas by providing active and adequate oxygenation is a core aspect of treating patients with acute respiratory distress syndrome (ARDS). The airway pressure release ventilation (APRV) mode is increasingly accepted as a means of supporting patients with ARDS. This study aimed to determine whether the APRV mode is effective in improving oxygenation, compared to conventional ventilation, in adult ARDS patients.

Methods: We conducted the study according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched for clinical trials in PubMed, Embase, Web of Science, and the Cochrane Library until April 2019. We included all studies comparing APRV and other conventional mechanical ventilation modes for adult ARDS patients. Our primary outcome was oxygenation status (defined as the day 3 PaO2/FiO2 ratio). The secondary outcomes were the length of stay (LOS) in the intensive care unit (ICU) and mortality. Sensitivity analyses were performed including studies with conventional low-tidal volume ventilation as a comparator ventilation strategy.

Results: We included six clinical trials enrolling a total of 375 patients. The day 3 PaO2/FiO2 was reported in all the studies, and it was significantly higher in patients receiving APRV (mean difference [MD] 51.9 mmHg, 95% confidence intervals (CI) 8.2-95.5, P = 0.02, I 2= 92%). There was no significant difference in mortality between APRV and the other conventional ventilator modes (risk difference 0.07, 95% CI: -0.01-0.15, P = 0.08, I 20%). The point estimate for the effect of APRV on the LOS in ICU indicated a significant reduction in the ICU LOS for the APRV group compared to the counter group (MD 3.1 days, 95% CI 0.4-5.9, P = 0.02, I 2= 53%).

Conclusion: In this study, using the APRV mode may improve oxygenation on day 3 and contribute to reducing the LOS in ICU. However, it is difficult to draw a clinical message about APRV, and well-designed clinical trials are required to investigate this issue.

背景:通过提供积极和充分的氧合来招募通风不良的肺部区域是治疗急性呼吸窘迫综合征(ARDS)患者的核心方面。气道压力释放通气(APRV)模式作为支持ARDS患者的一种手段越来越被接受。本研究旨在确定在成人ARDS患者中,与传统通气相比,APRV模式是否能有效改善氧合。方法:我们根据系统评价的首选报告项目和荟萃分析指南进行研究。我们在PubMed、Embase、Web of Science和Cochrane图书馆搜索临床试验,直到2019年4月。我们纳入了所有比较成年ARDS患者APRV和其他常规机械通气模式的研究。我们的主要结果是氧合状态(定义为第3天的PaO2/FiO2比率)。次要结果是重症监护室(ICU)的住院时间(LOS)和死亡率。进行了敏感性分析,包括将常规低潮气量通气作为对照通气策略的研究。结果:我们纳入了6项临床试验,共纳入375名患者。所有研究都报告了第3天的PaO2/FiO2,并且在接受APRV的患者中显著更高(平均差异[MD]51.9 mmHg,95%置信区间(CI)8.2-95.5,P=0.02,I2=92%)。APRV和其他常规呼吸机模式的死亡率没有显著差异(风险差异0.07,95%CI:-0.01-0.15,P=0.08,I 20%)。APRV对ICU服务水平影响的点估计表明,与对照组相比,APRV组的ICU服务水平显著降低(MD 3.1天,95%CI 0.4-5.9,P=0.02,I2=53%)。结论:在本研究中,使用APRV模式可以改善第3天的氧合,并有助于降低ICU的LOS。然而,很难得出关于APRV的临床信息,需要精心设计的临床试验来研究这个问题。
{"title":"The efficacy of airway pressure release ventilation in acute respiratory distress syndrome adult patients: A meta-analysis of clinical trials.","authors":"Fatmah Othman, Noura Alsagami, Reem Alharbi, Yara Almuammer, Shatha Alshahrani, Taha Ismaeil","doi":"10.4103/atm.ATM_475_20","DOIUrl":"10.4103/atm.ATM_475_20","url":null,"abstract":"<p><strong>Background: </strong>To recruit poorly ventilated lung areas by providing active and adequate oxygenation is a core aspect of treating patients with acute respiratory distress syndrome (ARDS). The airway pressure release ventilation (APRV) mode is increasingly accepted as a means of supporting patients with ARDS. This study aimed to determine whether the APRV mode is effective in improving oxygenation, compared to conventional ventilation, in adult ARDS patients.</p><p><strong>Methods: </strong>We conducted the study according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched for clinical trials in PubMed, Embase, Web of Science, and the Cochrane Library until April 2019. We included all studies comparing APRV and other conventional mechanical ventilation modes for adult ARDS patients. Our primary outcome was oxygenation status (defined as the day 3 PaO<sub>2</sub>/FiO<sub>2</sub> ratio). The secondary outcomes were the length of stay (LOS) in the intensive care unit (ICU) and mortality. Sensitivity analyses were performed including studies with conventional low-tidal volume ventilation as a comparator ventilation strategy.</p><p><strong>Results: </strong>We included six clinical trials enrolling a total of 375 patients. The day 3 PaO<sub>2</sub>/FiO<sub>2</sub> was reported in all the studies, and it was significantly higher in patients receiving APRV (mean difference [MD] 51.9 mmHg, 95% confidence intervals (CI) 8.2-95.5, <i>P</i> = 0.02, <i>I</i> <sup>2</sup>= 92%). There was no significant difference in mortality between APRV and the other conventional ventilator modes (risk difference 0.07, 95% CI: -0.01-0.15, <i>P</i> = 0.08, <i>I</i> <sup>2</sup>0%). The point estimate for the effect of APRV on the LOS in ICU indicated a significant reduction in the ICU LOS for the APRV group compared to the counter group (MD 3.1 days, 95% CI 0.4-5.9, <i>P</i> = 0.02, <i>I</i> <sup>2</sup>= 53%).</p><p><strong>Conclusion: </strong>In this study, using the APRV mode may improve oxygenation on day 3 and contribute to reducing the LOS in ICU. However, it is difficult to draw a clinical message about APRV, and well-designed clinical trials are required to investigate this issue.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/db/ATM-16-245.PMC8388564.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39385980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fatal rapidly progressive interstitial lung disease in a patient with amyopathic dermatomyositis. 致死性快速进行性间质性肺病1例肌炎患者。
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2021-07-01 Epub Date: 2021-07-20 DOI: 10.4103/atm.atm_739_20
Abdullah Mobeireek, Walter Conca, Shamayel Mohammed, Fahad AlObaid, Mohammed AlHajji

Interstitial lung disease (ILD) is a well-established common manifestation of idiopathic inflammatory myopathies. Yet, till now, the pathogenetic mechanisms are still poorly understood, classification is evolving and prognosis is variable. A refractory and rapidly progressive ILD (RPILD) that is associated with dermatomyositis (DM) with minimal muscle weakness and normal creatine kinase (termed clinically amyopathic DM) is increasingly being recognized, with more incidence in Asians. However, we are not aware of reports of the Arab region. Herein, we present a 38-year-old male with this condition that ended with a fatal outcome despite aggressive therapy, with a review of recent literature.

间质性肺疾病(ILD)是一种公认的特发性炎性肌病的常见表现。然而,迄今为止,其发病机制尚不清楚,分类也在不断发展,预后也不稳定。一种难治性和快速进展的ILD (RPILD)与皮肌炎(DM)相关,伴有轻微的肌肉无力和正常的肌酸激酶(临床上称为amyopathic DM),越来越多地被认识到,在亚洲发病率更高。但是,我们不知道有关阿拉伯地区的报告。在此,我们提出了一个38岁的男性与这种情况,结束了致命的结果,尽管积极的治疗,并回顾了最近的文献。
{"title":"Fatal rapidly progressive interstitial lung disease in a patient with amyopathic dermatomyositis.","authors":"Abdullah Mobeireek,&nbsp;Walter Conca,&nbsp;Shamayel Mohammed,&nbsp;Fahad AlObaid,&nbsp;Mohammed AlHajji","doi":"10.4103/atm.atm_739_20","DOIUrl":"https://doi.org/10.4103/atm.atm_739_20","url":null,"abstract":"<p><p>Interstitial lung disease (ILD) is a well-established common manifestation of idiopathic inflammatory myopathies. Yet, till now, the pathogenetic mechanisms are still poorly understood, classification is evolving and prognosis is variable. A refractory and rapidly progressive ILD (RPILD) that is associated with dermatomyositis (DM) with minimal muscle weakness and normal creatine kinase (termed clinically amyopathic DM) is increasingly being recognized, with more incidence in Asians. However, we are not aware of reports of the Arab region. Herein, we present a 38-year-old male with this condition that ended with a fatal outcome despite aggressive therapy, with a review of recent literature.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/40/ATM-16-294.PMC8388568.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39403527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Post-COVID-19 functional status: Relation to age, smoking, hospitalization, and previous comorbidities. covid -19后功能状态:与年龄、吸烟、住院和既往合并症有关。
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2021-07-01 Epub Date: 2021-07-20 DOI: 10.4103/atm.atm_606_20
Aliae Ar Mohamed Hussein, Mahmoud Saad, Hossam E Zayan, Mustafa Abdelsayed, Mohamed Moustafa, Abdel Rahman Ezzat, Radwa Helmy, Howaida Abd-Elaal, Karim Aly, Shaimaa Abdelrheem, Islam Sayed

Rational: Recently, a new "Post-COVID-19 Functional Status (PCFS) scale" is recommended in the current COVID-19 pandemic. It is proposed that it could be used to display direct retrieval and the functional sequelae of COVID-19.

Aim of the study: The aim of the study was to assess the PCFS and to evaluate if age, gender, smoking, hospitalization, and comorbidities have any effect on functional limitations in recovered COVID-19 patients.

Methods: A total of 444 registered confirmed COVID-19 patients were included. They were interviewed in our follow-up clinics and filled an Arabic translated PCFS scale as well as their demographic and clinical data.

Results: Eighty percent of COVID-19 recovered cases have diverse degrees of functional restrictions ranging from negligible (63.1%), slight (14.4%), moderate (2%), to severe (0.5%) based on PCFS. Furthermore, there was a substantial variance between the score of PCFS with age (P = 0.003), gender (P = 0.014), the duration since the onset of the symptoms of COVID-19 (P < 0.001), need for oxygen supplementation (P < 0.001), need for intensive care unit (ICU) admittance (P = 0.003), previous periodic influenza vaccination (P < 0.001), smoking status (P < 0.001), and finally, the presence of any comorbid disorder (P < 0.001).

Conclusions: Most of the COVID-19 recovered cases have diverse degrees of functional restrictions ranging from negligible to severe based on PCFS. These restrictions were affected by age, gender, periodic influenza vaccination, smoking, duration since symptoms onset, need for oxygen or ICU admittance, and finally the presence of coexisting comorbidity.

最近,在当前的COVID-19大流行中,推荐了新的“后COVID-19功能状态(PCFS)量表”。建议将其用于显示COVID-19的直接检索和功能后遗症。研究目的:本研究的目的是评估PCFS,并评估年龄、性别、吸烟、住院和合并症是否对康复的COVID-19患者的功能限制有任何影响。方法:共纳入444例登记的新冠肺炎确诊患者。他们在我们的随访诊所接受了采访,并填写了阿拉伯语翻译的PCFS量表以及他们的人口统计和临床数据。结果:80%的COVID-19康复病例存在不同程度的功能限制,根据PCFS分为可忽略(63.1%)、轻度(14.4%)、中度(2%)和重度(0.5%)。此外,PCFS评分与年龄(P = 0.003)、性别(P = 0.014)、出现COVID-19症状的持续时间(P < 0.001)、是否需要补充氧气(P < 0.001)、是否需要入住重症监护病房(ICU) (P = 0.003)、是否定期接种流感疫苗(P < 0.001)、是否吸烟(P < 0.001)以及是否存在任何共病性疾病(P < 0.001)之间存在显著差异。结论:基于PCFS,大多数COVID-19康复病例存在不同程度的功能限制,从可忽略到严重不等。这些限制受年龄、性别、定期流感疫苗接种、吸烟、症状出现的持续时间、需要吸氧或进入ICU以及最后是否存在共存的合并症的影响。
{"title":"Post-COVID-19 functional status: Relation to age, smoking, hospitalization, and previous comorbidities.","authors":"Aliae Ar Mohamed Hussein,&nbsp;Mahmoud Saad,&nbsp;Hossam E Zayan,&nbsp;Mustafa Abdelsayed,&nbsp;Mohamed Moustafa,&nbsp;Abdel Rahman Ezzat,&nbsp;Radwa Helmy,&nbsp;Howaida Abd-Elaal,&nbsp;Karim Aly,&nbsp;Shaimaa Abdelrheem,&nbsp;Islam Sayed","doi":"10.4103/atm.atm_606_20","DOIUrl":"https://doi.org/10.4103/atm.atm_606_20","url":null,"abstract":"<p><strong>Rational: </strong>Recently, a new \"Post-COVID-19 Functional Status (PCFS) scale\" is recommended in the current COVID-19 pandemic. It is proposed that it could be used to display direct retrieval and the functional sequelae of COVID-19.</p><p><strong>Aim of the study: </strong>The aim of the study was to assess the PCFS and to evaluate if age, gender, smoking, hospitalization, and comorbidities have any effect on functional limitations in recovered COVID-19 patients.</p><p><strong>Methods: </strong>A total of 444 registered confirmed COVID-19 patients were included. They were interviewed in our follow-up clinics and filled an Arabic translated PCFS scale as well as their demographic and clinical data.</p><p><strong>Results: </strong>Eighty percent of COVID-19 recovered cases have diverse degrees of functional restrictions ranging from negligible (63.1%), slight (14.4%), moderate (2%), to severe (0.5%) based on PCFS. Furthermore, there was a substantial variance between the score of PCFS with age (<i>P</i> = 0.003), gender (<i>P</i> = 0.014), the duration since the onset of the symptoms of COVID-19 (<i>P</i> < 0.001), need for oxygen supplementation (<i>P</i> < 0.001), need for intensive care unit (ICU) admittance (<i>P</i> = 0.003), previous periodic influenza vaccination (<i>P</i> < 0.001), smoking status (<i>P</i> < 0.001), and finally, the presence of any comorbid disorder (<i>P</i> < 0.001).</p><p><strong>Conclusions: </strong>Most of the COVID-19 recovered cases have diverse degrees of functional restrictions ranging from negligible to severe based on PCFS. These restrictions were affected by age, gender, periodic influenza vaccination, smoking, duration since symptoms onset, need for oxygen or ICU admittance, and finally the presence of coexisting comorbidity.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f9/22/ATM-16-260.PMC8388571.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39386393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 25
Clinical profiles associated with SARS-CoV-2 infection and complications from coronavirus disease-2019 in children from a national registry in Saudi Arabia. 沙特阿拉伯国家登记处2019年儿童严重急性呼吸系统综合征冠状病毒2型感染和冠状病毒疾病并发症的临床资料。
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2021-07-01 Epub Date: 2021-07-20 DOI: 10.4103/atm.atm_709_20
Yasir Almuzaini, Fahad Alsohime, Sarah Al Subaie, Mohamad Hani Temsah, Yousef Alsofayan, Fahad Alamri, Ahmed Alahmari, Hadil Alahdal, Hana Sonbol, Rana Almaghrabi, Mahmoud Nahhas, Anas Khan

Context: Exploring clinical characteristics of coronavirus disease-19 (COVID-19) in children may help in prevention and treatment guidelines.

Aims: The aim of the to describe the spectrum of pediatric COVID-19 in Saudi Arabia.

Settings and design: A multicenter, retrospective, cross-sectional study involving pediatric COVID-19 patients across all Saudi regions.

Methods: All patients aged between 2 months and 18 years with a confirmed diagnosis of COVID-19 were included. The primary end point was the hospitalization.

Statistical analysis used: Descriptive statistics were used to describe the baseline demographic data and clinical characteristics. Numerical data were explored using Kolmogorov-Smirnov test and Shapiro-Wilk test, while Chi-square or Fisher's exact test were used for categorical data.

Results: Among the 654 pediatric COVID-19 patients, 4.7% (n = 31) were hospitalized, with one patient only needing pediatric intensive care admission. Sex, breastfeeding, birth status, and the patients' living environment showed no significant association with hospitalization. Most children (80.3%, n = 525) were symptomatic, with two symptoms that were significantly associated with admission, namely, vomiting (P = 0.007) and nausea (P = 0.026). History of admission within the last year was identified in 10.4% (n = 68) children but had no association with worse outcome. The median duration of hospitalization for the entire group was 5.5 days, with longest hospital stay for age group 7-12 years (median 6 days).

Conclusions: COVID-19 is usually a milder disease in children. Although having preexisting medical conditions was linked to a longer hospitalization, it was not associated with worse outcome. Continuous surveillance will allow additional characterization of the burden and outcomes of pediatric COVID-19-associated hospitalizations.

背景:探索儿童冠状病毒疾病19(新冠肺炎)的临床特征可能有助于制定预防和治疗指南。目的:旨在描述沙特阿拉伯儿科新冠肺炎的发病谱。设置和设计:一项涉及沙特所有地区儿科新冠肺炎患者的多中心、回顾性、横断面研究。方法:纳入所有年龄在2个月至18岁之间确诊为新冠肺炎的患者。主要终点是住院治疗。使用统计分析:描述性统计用于描述基线人口统计数据和临床特征。数值数据采用Kolmogorov-Smirnov检验和Shapiro-Wilk检验,分类数据采用卡方检验或Fisher精确检验。结果:在654名新冠肺炎儿科患者中,4.7%(n=31)住院,其中一名患者只需要接受儿科重症监护。性别、母乳喂养、出生状况和患者的生活环境与住院治疗没有显著关联。大多数儿童(80.3%,n=525)有症状,有两种症状与入院显著相关,即呕吐(P=0.007)和恶心(P=0.026)。10.4%(n=68)的儿童在过去一年内有入院史,但与更糟糕的结果无关。整个组的平均住院时间为5.5天,7-12岁年龄组的住院时间最长(平均6天)。结论:新冠肺炎通常是一种较轻的儿童疾病。尽管先前存在的疾病与更长的住院时间有关,但与更糟糕的结果无关。持续监测将有助于进一步确定儿童COVID-19相关住院的负担和结果。
{"title":"Clinical profiles associated with SARS-CoV-2 infection and complications from coronavirus disease-2019 in children from a national registry in Saudi Arabia.","authors":"Yasir Almuzaini,&nbsp;Fahad Alsohime,&nbsp;Sarah Al Subaie,&nbsp;Mohamad Hani Temsah,&nbsp;Yousef Alsofayan,&nbsp;Fahad Alamri,&nbsp;Ahmed Alahmari,&nbsp;Hadil Alahdal,&nbsp;Hana Sonbol,&nbsp;Rana Almaghrabi,&nbsp;Mahmoud Nahhas,&nbsp;Anas Khan","doi":"10.4103/atm.atm_709_20","DOIUrl":"10.4103/atm.atm_709_20","url":null,"abstract":"<p><strong>Context: </strong>Exploring clinical characteristics of coronavirus disease-19 (COVID-19) in children may help in prevention and treatment guidelines.</p><p><strong>Aims: </strong>The aim of the to describe the spectrum of pediatric COVID-19 in Saudi Arabia.</p><p><strong>Settings and design: </strong>A multicenter, retrospective, cross-sectional study involving pediatric COVID-19 patients across all Saudi regions.</p><p><strong>Methods: </strong>All patients aged between 2 months and 18 years with a confirmed diagnosis of COVID-19 were included. The primary end point was the hospitalization.</p><p><strong>Statistical analysis used: </strong>Descriptive statistics were used to describe the baseline demographic data and clinical characteristics. Numerical data were explored using Kolmogorov-Smirnov test and Shapiro-Wilk test, while Chi-square or Fisher's exact test were used for categorical data.</p><p><strong>Results: </strong>Among the 654 pediatric COVID-19 patients, 4.7% (<i>n</i> = 31) were hospitalized, with one patient only needing pediatric intensive care admission. Sex, breastfeeding, birth status, and the patients' living environment showed no significant association with hospitalization. Most children (80.3%, <i>n</i> = 525) were symptomatic, with two symptoms that were significantly associated with admission, namely, vomiting (<i>P</i> = 0.007) and nausea (<i>P</i> = 0.026). History of admission within the last year was identified in 10.4% (<i>n</i> = 68) children but had no association with worse outcome. The median duration of hospitalization for the entire group was 5.5 days, with longest hospital stay for age group 7-12 years (median 6 days).</p><p><strong>Conclusions: </strong>COVID-19 is usually a milder disease in children. Although having preexisting medical conditions was linked to a longer hospitalization, it was not associated with worse outcome. Continuous surveillance will allow additional characterization of the burden and outcomes of pediatric COVID-19-associated hospitalizations.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/dc/cc/ATM-16-280.PMC8388572.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39386394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Gone with the wind! Changes in the practice of bronchoscopy post pandemic: A perspective. 随风而逝!大流行后支气管镜检查实践的变化:视角
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2021-07-01 Epub Date: 2021-07-20 DOI: 10.4103/atm.atm_552_20
Himanshu Deshwal, Atul C Mehta, Mohammed Munavvar
From the first bronchoscopy in 1897, interventional pulmonologists (IP) have developed innovative technologies to improve diagnostic and therapeutic outcomes, revolutionizing the field of thoracic medicine.[2] Techniques and procedural preparation have also evolved to improve safety and minimize the risk of disease transmission. While the practice of interventional pulmonology continues to advance, the current COVID‐19 pandemic demands a conscientious, differential approach to any invasive or aerosol‐generating procedure. Studies have demonstrated that currently 6% of the total health‐care workforce has been infected by COVID‐19.[3] Emerging evidence suggests an airborne mode of transmission for COVID‐19, making the performance of bronchoscopy a high‐risk procedure.[4] In addition, the transmission of multidrug‐resistant microorganisms via bronchoscopy has necessitated the re‐defining of instrument decontamination, strict infection control policies, and prudent use of this revolutionary tool.[5] These critical challenges evoke core questions regarding the future of interventional pulmonology and the long‐lasting impact the pandemic may have on the practice of bronchoscopy.
{"title":"Gone with the wind! Changes in the practice of bronchoscopy post pandemic: A perspective.","authors":"Himanshu Deshwal,&nbsp;Atul C Mehta,&nbsp;Mohammed Munavvar","doi":"10.4103/atm.atm_552_20","DOIUrl":"https://doi.org/10.4103/atm.atm_552_20","url":null,"abstract":"From the first bronchoscopy in 1897, interventional pulmonologists (IP) have developed innovative technologies to improve diagnostic and therapeutic outcomes, revolutionizing the field of thoracic medicine.[2] Techniques and procedural preparation have also evolved to improve safety and minimize the risk of disease transmission. While the practice of interventional pulmonology continues to advance, the current COVID‐19 pandemic demands a conscientious, differential approach to any invasive or aerosol‐generating procedure. Studies have demonstrated that currently 6% of the total health‐care workforce has been infected by COVID‐19.[3] Emerging evidence suggests an airborne mode of transmission for COVID‐19, making the performance of bronchoscopy a high‐risk procedure.[4] In addition, the transmission of multidrug‐resistant microorganisms via bronchoscopy has necessitated the re‐defining of instrument decontamination, strict infection control policies, and prudent use of this revolutionary tool.[5] These critical challenges evoke core questions regarding the future of interventional pulmonology and the long‐lasting impact the pandemic may have on the practice of bronchoscopy.","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fe/1f/ATM-16-221.PMC8388567.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39385978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Small-airway disease and its reversibility in human immunodeficiency virus-infected children on highly active antiretroviral therapy: A cross-sectional study in an African setting. 在高度有效的抗逆转录病毒治疗中,人类免疫缺陷病毒感染儿童的小气道疾病及其可逆性:在非洲环境中的横断面研究。
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2021-07-01 Epub Date: 2021-07-20 DOI: 10.4103/atm.ATM_494_20
Adaeze C Ayuk, Chizalu I Ndukwu, Samuel N Uwaezuoke

Background: Lung function abnormalities may occur in children with human immunodeficiency virus (HIV) infection. Small-airway disease (SAD) precedes abnormalities in forced expiratory volume in 1 s (FEV 1).

Objective: This study aims to assess the presence and reversibility of SAD in HIV-infected children using the Global Lung Function Initiative standards.

Methods: A cross-sectional study was conducted over 6 months at the Paediatric HIV Clinic of the University of Nigeria Teaching Hospital in Enugu, Southeast Nigeria. Eligible consenting children with HIV infection were recruited. Lung function was measured, and the reversibility of FEV1 and forced vital capacity (FVC) was assessed at 12% while that of forced expiratory flow between 25% and 75% (FEF25-75) was assessed at 12%, 15%, and 20%. Predictors of abnormal Z-score values were determined by multivariate linear and logistic regressions. Statistically significant values were set at P < 0.05.

Results: The mean Z-score for FEV1, FVC, and FEF25-75 was - 2.19, -1.86, and - 1.60, respectively. Most patients (73%) had abnormal FEV1, while 52% had abnormal FEF25-75. Significant changes in FEV1 (P = 0.001) and FEF25-75 (P < 0.001) occurred after the bronchodilator response (BDR) test. Of the children whose FEV1 showed positive BDR, 70.9% had low zFEV1; 50% had low zFEF25-75, while all had low FEV1. Nutritional status (Z-score for body mass index) was significantly associated with low FEV1.

Conclusions: Abnormal FEF25-75 as a marker of SAD and FEV1 with a positive BDR are common in HIV-infected children. These lung function abnormalities justify long-term follow-up for these patients.

背景:感染人类免疫缺陷病毒(HIV)的儿童可能出现肺功能异常。小气道疾病(SAD)先于1 s用力呼气量(FEV 1)异常。目的:本研究旨在使用全球肺功能倡议标准评估hiv感染儿童中SAD的存在和可逆性。方法:在尼日利亚东南部埃努古的尼日利亚大学教学医院儿科艾滋病毒诊所进行了为期6个月的横断面研究。招募了符合条件的艾滋病毒感染儿童。测量肺功能,在12%时评估FEV1和用力肺活量(FVC)的可逆性,在12%、15%和20%时评估用力呼气流量在25%至75%之间(FEF25-75)的可逆性。通过多元线性和逻辑回归确定异常z评分值的预测因子。差异有统计学意义,P < 0.05。结果:FEV1、FVC、FEF25-75的Z-score平均值分别为- 2.19、-1.86、- 1.60。大多数患者(73%)FEV1异常,52%患者FEF25-75异常。支气管扩张剂反应(BDR)试验后,FEV1 (P = 0.001)和FEF25-75 (P < 0.001)发生显著变化。在FEV1 BDR阳性的患儿中,70.9%为低zFEV1;50%患者zfef25 ~ 75较低,FEV1均较低。营养状况(身体质量指数z得分)与低FEV1显著相关。结论:FEF25-75异常是SAD和FEV1的标志,BDR阳性在hiv感染儿童中很常见。这些肺功能异常证明对这些患者进行长期随访是合理的。
{"title":"Small-airway disease and its reversibility in human immunodeficiency virus-infected children on highly active antiretroviral therapy: A cross-sectional study in an African setting.","authors":"Adaeze C Ayuk,&nbsp;Chizalu I Ndukwu,&nbsp;Samuel N Uwaezuoke","doi":"10.4103/atm.ATM_494_20","DOIUrl":"https://doi.org/10.4103/atm.ATM_494_20","url":null,"abstract":"<p><strong>Background: </strong>Lung function abnormalities may occur in children with human immunodeficiency virus (HIV) infection. Small-airway disease (SAD) precedes abnormalities in forced expiratory volume in 1 s (FEV <sub>1</sub>).</p><p><strong>Objective: </strong>This study aims to assess the presence and reversibility of SAD in HIV-infected children using the Global Lung Function Initiative standards.</p><p><strong>Methods: </strong>A cross-sectional study was conducted over 6 months at the Paediatric HIV Clinic of the University of Nigeria Teaching Hospital in Enugu, Southeast Nigeria. Eligible consenting children with HIV infection were recruited. Lung function was measured, and the reversibility of FEV<sub>1</sub> and forced vital capacity (FVC) was assessed at 12% while that of forced expiratory flow between 25% and 75% (FEF<sub>25-75</sub>) was assessed at 12%, 15%, and 20%. Predictors of abnormal Z-score values were determined by multivariate linear and logistic regressions. Statistically significant values were set at <i>P</i> < 0.05.</p><p><strong>Results: </strong>The mean Z-score for FEV<sub>1</sub>, FVC, and FEF<sub>25-75</sub> was - 2.19, -1.86, and - 1.60, respectively. Most patients (73%) had abnormal FEV<sub>1</sub>, while 52% had abnormal FEF<sub>25-75</sub>. Significant changes in FEV<sub>1</sub> (<i>P</i> = 0.001) and FEF<sub>25-75</sub> (<i>P</i> < 0.001) occurred after the bronchodilator response (BDR) test. Of the children whose FEV<sub>1</sub> showed positive BDR, 70.9% had low zFEV<sub>1;</sub> 50% had low zFEF<sub>25-75</sub>, while all had low FEV<sub>1.</sub> Nutritional status (Z-score for body mass index) was significantly associated with low FEV<sub>1.</sub></p><p><strong>Conclusions: </strong>Abnormal FEF<sub>25-75</sub> as a marker of SAD and FEV<sub>1</sub> with a positive BDR are common in HIV-infected children. These lung function abnormalities justify long-term follow-up for these patients.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d6/45/ATM-16-253.PMC8388566.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39386387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The recommended amount of physical activity, sedentary behavior, and sleep duration for healthy Saudis: A joint consensus statement of the Saudi Public Health Authority. 健康沙特人的推荐运动量、久坐行为和睡眠时间:沙特公共卫生当局的联合共识声明。
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2021-07-01 Epub Date: 2021-07-20 DOI: 10.4103/atm.atm_33_21
Rasha A Alfawaz, Ghadeer S Aljuraiban, Mezna A AlMarzooqi, Abdullah F Alghannam, Ahmed S BaHammam, Ali M Dobia, Shaima A Alothman, Osama Aljuhani, Khalid Saad Aljaloud

Background: The goal of the 24-h Movement Practice Guidelines for Saudi Arabia is to provide policymakers, health-care providers, researchers, sports professionals, and members of the public with recommendations on the duration of time they should spend engaged in physical activity, sedentary behavior, and sleep throughout all age groups.

Methods: A modified RAND appropriateness method and the "GRADE-ADOLOPMENT" approach of guideline recommendations were used by a guideline development panel to develop the present recommendations.

Results: The recommendations were based on the integrated needs of the following age groups: children (0-2 years), preschoolers (3-5 years), children and adolescents (6-17 years), adults (18-64 years), and older adults (≥65 years). The guidelines also include special considerations for sleep duration in the Saudi culture, such as dawn prayer and Ramadan.

Conclusions: Several research gaps in physical activity, sedentary behavior, and sleep were identified and highlighted by the guideline development panel for potential future research.

背景:《沙特阿拉伯24小时运动实践指南》的目标是为政策制定者、卫生保健提供者、研究人员、体育专业人员和公众提供建议,建议所有年龄组的人应该花多长时间从事体育活动、久坐行为和睡眠。方法:一个指南制定小组采用改良的RAND适宜性方法和指南建议的“分级-采用”方法来制定本指南。结果:建议基于以下年龄组的综合需求:儿童(0-2岁)、学龄前儿童(3-5岁)、儿童和青少年(6-17岁)、成人(18-64岁)和老年人(≥65岁)。该指南还包括沙特文化中对睡眠时间的特殊考虑,比如黎明祈祷和斋月。结论:指南制定小组确定并强调了在身体活动、久坐行为和睡眠方面的几个研究空白,以便进行潜在的未来研究。
{"title":"The recommended amount of physical activity, sedentary behavior, and sleep duration for healthy Saudis: A joint consensus statement of the Saudi Public Health Authority.","authors":"Rasha A Alfawaz,&nbsp;Ghadeer S Aljuraiban,&nbsp;Mezna A AlMarzooqi,&nbsp;Abdullah F Alghannam,&nbsp;Ahmed S BaHammam,&nbsp;Ali M Dobia,&nbsp;Shaima A Alothman,&nbsp;Osama Aljuhani,&nbsp;Khalid Saad Aljaloud","doi":"10.4103/atm.atm_33_21","DOIUrl":"https://doi.org/10.4103/atm.atm_33_21","url":null,"abstract":"<p><strong>Background: </strong>The goal of the 24-h Movement Practice Guidelines for Saudi Arabia is to provide policymakers, health-care providers, researchers, sports professionals, and members of the public with recommendations on the duration of time they should spend engaged in physical activity, sedentary behavior, and sleep throughout all age groups.</p><p><strong>Methods: </strong>A modified RAND appropriateness method and the \"GRADE-ADOLOPMENT\" approach of guideline recommendations were used by a guideline development panel to develop the present recommendations.</p><p><strong>Results: </strong>The recommendations were based on the integrated needs of the following age groups: children (0-2 years), preschoolers (3-5 years), children and adolescents (6-17 years), adults (18-64 years), and older adults (≥65 years). The guidelines also include special considerations for sleep duration in the Saudi culture, such as dawn prayer and Ramadan.</p><p><strong>Conclusions: </strong>Several research gaps in physical activity, sedentary behavior, and sleep were identified and highlighted by the guideline development panel for potential future research.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/be/e7/ATM-16-239.PMC8388570.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39386388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Pulmonary neuroendocrine carcinoid tumors: Is there a predictive role to the Ki 67 index? 肺神经内分泌类癌:Ki 67指数是否有预测作用?
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2021-07-01 Epub Date: 2021-07-20 DOI: 10.4103/atm.atm_599_20
Ana Karina Patané, Gabriela Guma, Mercedes Rayá, Adolfo Rosales, Walter Astorino, Moisés Rosenberg

Introduction: There are several factors predicting evolution in carcinoid tumors (CT) to date including the Ki67 role.

Aims: The aim of this study is to identify a KI67 cut-off point for a population of CT and determine its prognostic implication in global and disease-free survival.

Methods: Hematoxylin-eosin slides of 102 CT were revised. The percentage of cells expressing Ki 67 was determined manually.

Statistical analysis: The variables were compared with the t-test or the Wilcoxon test according to their distribution, the categorical ones with Chi-square or Fisher's test. The best cut-off point was established by constructing receiver operating characteristic curves, then using that value as a dichotomous variable.

Results: 72 typical carcinoids (TC) and 30 atypical carcinoids (AC) were analyzed; 66% were female. Median age (TC 38 vs. AC 51, P = 0.001), Ki67 expression (TC 0.63 vs. AC 2, P = 0.003), tumor size (TC 2.5 vs. AC 2.6, P = 0.001), the percentage relapse (TC 3.4% vs. AC 23%, P = 0.006), and the number of deaths (TC 1 vs. AC 4, P = 0.042) were significantly higher in the AC subgroup. The best cut-off point for Ki 67 was 0.755 (area under the curve AUC 0.564, 95% confidence interval 0.270-0.857), with no significant differences found in the disease-free and overall survival curves when considering values < or ≥ at the established cut-off point. The best cut-off point of the Ki-67 when exclusively analyzing AC was 1.18. When using this value as a predictive variable, a marginal statistical association was observed between Ki-67 expression, mortality (P = 0.077), and the frequency of relapses (P = 0.054).

Conclusions: Histological type is the best predictor of prognosis in the carcinoid tumor group. In the AC subgroup, the marginal association between mortality, frequency of relapses and Ki values 67 ≥ 1.18 has clinical relevance future analyses are required to determine the real predictive value of this variable.

迄今为止,有几个因素可以预测类癌肿瘤(CT)的演变,包括Ki67的作用。目的:本研究的目的是确定CT人群的KI67分界点,并确定其在全球和无病生存中的预后意义。方法:对102 CT的苏木精-伊红切片进行修改。人工测定表达ki67的细胞百分比。统计分析:根据变量的分布情况采用t检验或Wilcoxon检验,分类变量采用卡方检验或Fisher检验。通过构造患者工作特征曲线,确定最佳分界点,并将该值作为二分类变量。结果:分析了72例典型类癌(TC)和30例非典型类癌(AC);66%是女性。AC亚组的中位年龄(TC 38 vs AC 51, P = 0.001)、Ki67表达(TC 0.63 vs AC 2, P = 0.003)、肿瘤大小(TC 2.5 vs AC 2.6, P = 0.001)、复发率(TC 3.4% vs AC 23%, P = 0.006)和死亡人数(TC 1 vs AC 4, P = 0.042)均显著高于AC亚组。Ki 67的最佳截断点为0.755(曲线下面积AUC为0.564,95%可信区间为0.270-0.857),在确定的截断点考虑值<或≥时,无病生存曲线和总生存曲线无显著差异。Ki-67单独分析AC时的最佳截断点为1.18。当使用该值作为预测变量时,Ki-67表达、死亡率(P = 0.077)和复发频率(P = 0.054)之间存在边际统计学关联。结论:在类癌组中,组织学类型是预测预后的最佳指标。在AC亚组中,死亡率、复发频率和Ki值67≥1.18之间的边际相关性具有临床相关性,需要进一步的分析来确定该变量的真实预测值。
{"title":"Pulmonary neuroendocrine carcinoid tumors: Is there a predictive role to the Ki 67 index?","authors":"Ana Karina Patané,&nbsp;Gabriela Guma,&nbsp;Mercedes Rayá,&nbsp;Adolfo Rosales,&nbsp;Walter Astorino,&nbsp;Moisés Rosenberg","doi":"10.4103/atm.atm_599_20","DOIUrl":"https://doi.org/10.4103/atm.atm_599_20","url":null,"abstract":"<p><strong>Introduction: </strong>There are several factors predicting evolution in carcinoid tumors (CT) to date including the Ki67 role.</p><p><strong>Aims: </strong>The aim of this study is to identify a KI67 cut-off point for a population of CT and determine its prognostic implication in global and disease-free survival.</p><p><strong>Methods: </strong>Hematoxylin-eosin slides of 102 CT were revised. The percentage of cells expressing Ki 67 was determined manually.</p><p><strong>Statistical analysis: </strong>The variables were compared with the t-test or the Wilcoxon test according to their distribution, the categorical ones with Chi-square or Fisher's test. The best cut-off point was established by constructing receiver operating characteristic curves, then using that value as a dichotomous variable.</p><p><strong>Results: </strong>72 typical carcinoids (TC) and 30 atypical carcinoids (AC) were analyzed; 66% were female. Median age (TC 38 vs. AC 51, <i>P</i> = 0.001), Ki67 expression (TC 0.63 vs. AC 2, <i>P</i> = 0.003), tumor size (TC 2.5 vs. AC 2.6, <i>P</i> = 0.001), the percentage relapse (TC 3.4% vs. AC 23%, <i>P</i> = 0.006), and the number of deaths (TC 1 vs. AC 4, <i>P</i> = 0.042) were significantly higher in the AC subgroup. The best cut-off point for Ki 67 was 0.755 (area under the curve AUC 0.564, 95% confidence interval 0.270-0.857), with no significant differences found in the disease-free and overall survival curves when considering values < or ≥ at the established cut-off point. The best cut-off point of the Ki-67 when exclusively analyzing AC was 1.18. When using this value as a predictive variable, a marginal statistical association was observed between Ki-67 expression, mortality (<i>P</i> = 0.077), and the frequency of relapses (<i>P</i> = 0.054).</p><p><strong>Conclusions: </strong>Histological type is the best predictor of prognosis in the carcinoid tumor group. In the AC subgroup, the marginal association between mortality, frequency of relapses and Ki values 67 ≥ 1.18 has clinical relevance future analyses are required to determine the real predictive value of this variable.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1a/be/ATM-16-274.PMC8388565.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39386391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Molecular detection of plasmid-derived AmpC β-lactamase among clinical strains of Enterobacteriaceae in Bahrain. 巴林肠杆菌科临床菌株质粒源AmpC β-内酰胺酶的分子检测。
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2021-07-01 Epub Date: 2021-02-19 DOI: 10.4103/atm.ATM_523_20
Ronni Mol Joji, Ali Ebrahim Al-Mahameed, Thamer Al Jishi, Dania Ismail Fatani, Nermin K Saeed, Ahmed Jaradat, Hicham Ezzat, Khalid Mubarak Bindayna

Background: Enterobacteriaceae with AmpC β-lactamase are multidrug-resistant organisms and represent a significant challenge to patient care. This study aims to determine the prevalence of plasmid-derived AmpC β-lactamase among extended spectrum β-lactamases (ESBL)-producing Enterobacteriaceae strains in Bahrain.

Methods: It was a cross-sectional study. A total of 185 ESBL-producing Enterobacteriaceae isolates were recovered from clinically significant specimens from January 2018 to December 2019. The samples underwent initial screen for cefoxitin resistance by disc diffusion test and subsequent phenotypic confirmation of AmpC production with phenyl boronic acid assays as well as genotypic analysis by multiplex polymerase chain reactions for AmpC subtypes. Drug-resistant features of these clinical isolates were also examined.

Results: Twenty-nine ESBL-producing Enterobacteriaceae isolates were cefoxitin resistant. Phenotypic and genotypic analyses confirmed that 8 and 12 cefoxitin-resistant isolates are AmpC positive, respectively. These AmpC producers are multidrug resistant, and Escherichia coli is the dominant strain among them.

Conclusions: Plasmid-mediated spread of AmpC is present in clinically relevant Enterobacteriaceae species in Bahrain. Rational antimicrobial therapy against these multidrug-resistant organisms and continued surveillance of antimicrobial resistance mechanisms among the clinical isolates are recommended for optimal patient care.

背景:具有AmpC β-内酰胺酶的肠杆菌科是多重耐药生物,对患者护理构成重大挑战。本研究旨在确定质粒来源的AmpC β-内酰胺酶在巴林产扩展谱β-内酰胺酶(ESBL)肠杆菌科菌株中的流行程度。方法:采用横断面研究。2018年1月至2019年12月,从临床有意义的标本中共分离出185株产esbl的肠杆菌科菌株。通过圆盘扩散试验对样品进行头孢西丁耐药性初步筛选,随后用苯硼酸法对AmpC产生进行表型确认,并通过多重聚合酶链反应对AmpC亚型进行基因型分析。这些临床分离株的耐药特征也进行了检查。结果:29株产esbl肠杆菌科菌株对头孢西丁耐药。表型和基因型分析分别证实8株和12株头孢西丁耐药菌株AmpC阳性。这些AmpC生产者具有多重耐药,大肠杆菌是其中的优势菌株。结论:质粒介导的AmpC传播存在于巴林临床相关肠杆菌科物种中。建议对这些多重耐药微生物进行合理的抗菌治疗,并继续监测临床分离株的抗菌耐药机制,以获得最佳的患者护理。
{"title":"Molecular detection of plasmid-derived AmpC β-lactamase among clinical strains of <i>Enterobacteriaceae</i> in Bahrain.","authors":"Ronni Mol Joji,&nbsp;Ali Ebrahim Al-Mahameed,&nbsp;Thamer Al Jishi,&nbsp;Dania Ismail Fatani,&nbsp;Nermin K Saeed,&nbsp;Ahmed Jaradat,&nbsp;Hicham Ezzat,&nbsp;Khalid Mubarak Bindayna","doi":"10.4103/atm.ATM_523_20","DOIUrl":"https://doi.org/10.4103/atm.ATM_523_20","url":null,"abstract":"<p><strong>Background: </strong><i>Enterobacteriaceae</i> with AmpC β-lactamase are multidrug-resistant organisms and represent a significant challenge to patient care. This study aims to determine the prevalence of plasmid-derived AmpC β-lactamase among extended spectrum β-lactamases (ESBL)-producing <i>Enterobacteriaceae</i> strains in Bahrain.</p><p><strong>Methods: </strong>It was a cross-sectional study. A total of 185 ESBL-producing <i>Enterobacteriaceae</i> isolates were recovered from clinically significant specimens from January 2018 to December 2019. The samples underwent initial screen for cefoxitin resistance by disc diffusion test and subsequent phenotypic confirmation of AmpC production with phenyl boronic acid assays as well as genotypic analysis by multiplex polymerase chain reactions for AmpC subtypes. Drug-resistant features of these clinical isolates were also examined.</p><p><strong>Results: </strong>Twenty-nine ESBL-producing <i>Enterobacteriaceae</i> isolates were cefoxitin resistant. Phenotypic and genotypic analyses confirmed that 8 and 12 cefoxitin-resistant isolates are AmpC positive, respectively. These AmpC producers are multidrug resistant, and Escherichia coli is the dominant strain among them.</p><p><strong>Conclusions: </strong>Plasmid-mediated spread of AmpC is present in clinically relevant <i>Enterobacteriaceae</i> species in Bahrain. Rational antimicrobial therapy against these multidrug-resistant organisms and continued surveillance of antimicrobial resistance mechanisms among the clinical isolates are recommended for optimal patient care.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0f/a7/ATM-16-287.PMC8388573.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39403525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Annals of Thoracic Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1